Publication date: Aug 06, 2019
Old MS Drug May Improve Cognitive Function Old MS Drug May Improve Cognitive Function Dalfampridine, approved almost a decade ago for improving walking for patients with multiple sclerosis, may also improve information-processing speed, a measure of cognitive function, new research suggests. Medscape Medical News Purpose of review To review recent studies which assess comorbidity, that is, prevalence of co-occurrence, relationships and treatment implications between anxiety disorders and various medical illnesses. Recent findings The prevalence rates of anxiety disorders in patients with medical illnesses are high, with percentage up to 29% in patients with epilepsy, 48. 9% in patients with multiple sclerosis, 30. 1% in patients with Parkinson’s disease, 30% in patients with cardiovascular disease, 47. 0% in patients with diabetes mellitus, and so on. Source: – Category: Psychiatry Tags: PSYCHIATRY, MEDICINE AND THE BEHAVIOURAL SCIENCES: Edited by Mohan Isaac and Igor Filipcic Source Type: research PsychiatryPSYCHIATRY, MEDICINE AND THE BEHAVIOURAL SCIENCES: Edited by Mohan Isaac and Igor Filipcicresearch Profound and debilitating fatigue is the most common complaint reported among individuals with autoimmune disease, such as systemic lupus erythematosus, multiple sclerosis, type 1 diabetes, celiac disease, chronic fatigue syndrome, and rheumatoid arthritis. Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech Republic from 2013-2016: data from the national registry ReMuS Conclusion: Data from the ReMuS registry highlights improvements made in the management of MS in the Czech Republic. Role of diet and gut microbiota in multiple sclerosis: New findings on the role of high -salt intake in induction of neuroinflammation This article is a snapshot of the recent findings about the putative role of high-salt and high-fat intake in the pathogenesis of MS. AbstractMultiple etiological factors are involved in the pathogenesis of multiple sclerosis (MS). AbstractBackgroundHypertension is a prevalent and impactful comorbid condition among patients with multiple sclerosis (MS).